Generation Bio Co. (NASDAQ:GBIO – Get Free Report) saw a significant decrease in short interest in January. Generation Bio Stock PerformanceGeneration Bio stock traded down $0.09 during midday trading on Wednesday, reaching $5.58. Get Generation Bio alerts:Generation Bio (NASDAQ:GBIO – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. Generation Bio Company Profile(Get Free Report)Generation Bio, Inc (NASDAQ: GBIO) is a clinical-stage genetic medicine company dedicated to developing ultra-long-term non-viral gene therapies for serious, chronic diseases. See AlsoReceive News & Ratings for Generation Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generation Bio and related companies with MarketBeat.com's FREE daily email newsletter.